| Application no. and date | 11768163.5 (espacenet) (Federated) (European Patent Register), 20110920 | | Patent/reg. no. and date | DK/EP 2621493, 20160817 | | Publication date | 20130807 | | Priority no. and date | US 388102 P, 20100930 | | EP pub. no. and date |
EP 2621493 20130807 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | P81603917DK00E | | Inventor | DIDIUK, Mary Theresa, 61 Hickory Lane
Madison, Connecticut 06443, US,
DOW, Robert Lee, Pfizer Global Research and Development
Eastern Point Road
Groton, Connecticut 06340, US,
GRIFFITH, David Andrew, Pfizer Global Research and Development
87 Cambridge Park Drive
Cambridge, Massachusetts 02140, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/438 (2006.01) , A61P 3/10 (2006.01) , C07D 471/10 (2006.01) , C07D 491/20 (2006.01) | | Title | N1-PYRAZOLOSPIROKETON-ACETYL-CoA-CARBOXYLASE-INHIBITORER | | Int. application no. | IB2011054119 | | Int. publication no. | WO2012042433 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
